NeoGenomics, Inc. (NEO)
16.25
-0.10
(-0.61%)
USD |
NASDAQ |
Oct 12, 10:17
NeoGenomics Free Cash Flow (Quarterly) : 11.74M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.74M |
| March 31, 2026 | -13.14M |
| December 31, 2025 | -6.528M |
| September 30, 2025 | 0.57M |
| June 30, 2025 | 14.01M |
| March 31, 2025 | -29.83M |
| December 31, 2024 | -1.799M |
| September 30, 2024 | -1.553M |
| June 30, 2024 | 0.814M |
| March 31, 2024 | -31.50M |
| December 31, 2023 | 10.73M |
| September 30, 2023 | -9.771M |
| June 30, 2023 | -9.042M |
| March 31, 2023 | -22.62M |
| December 31, 2022 | -8.219M |
| September 30, 2022 | -24.12M |
| June 30, 2022 | -27.29M |
| March 31, 2022 | -37.26M |
| December 31, 2021 | -31.76M |
| September 30, 2021 | -22.74M |
| June 30, 2021 | -22.74M |
| March 31, 2021 | -13.62M |
| December 31, 2020 | -5.52M |
| September 30, 2020 | -7.331M |
| June 30, 2020 | -3.144M |
| Date | Value |
|---|---|
| March 31, 2020 | -11.64M |
| December 31, 2019 | -2.717M |
| September 30, 2019 | 11.32M |
| June 30, 2019 | -8.162M |
| March 31, 2019 | 2.901M |
| December 31, 2018 | 12.23M |
| September 30, 2018 | 6.233M |
| June 30, 2018 | 2.363M |
| March 31, 2018 | 9.646M |
| December 31, 2017 | 2.236M |
| September 30, 2017 | 5.133M |
| June 30, 2017 | 1.671M |
| March 31, 2017 | -4.693M |
| December 31, 2016 | -2.449M |
| September 30, 2016 | 7.72M |
| June 30, 2016 | 2.612M |
| March 31, 2016 | 6.058M |
| December 31, 2015 | 1.588M |
| September 30, 2015 | 1.872M |
| June 30, 2015 | 2.347M |
| March 31, 2015 | -1.629M |
| December 31, 2014 | -0.067M |
| September 30, 2014 | 2.413M |
| June 30, 2014 | 3.19M |
| March 31, 2014 | 0.142M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Precipio, Inc. | 0.528M |
| Quest Diagnostics, Inc. | 459.00M |
| Labcorp Holdings, Inc. | 313.90M |
| OPKO Health, Inc. | -46.50M |
| Psychemedics Corp. | -- |